Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 5,500 shares at $84.31 ($467K) on 2026-04-01, disclosed to the SEC on 2026-04-03.
Scheduled sale ($467k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.31 | 2,698 | $227K | 48.7% |
| 2 | $85.33 | 2,702 | $231K | 49.4% |
| 3 | $85.89 | 100 | $9K | 1.8% |
| Total | $84.84 avg | 5,500 | $467K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |